-
effectivehealthcare-admin.ahrq.gov/products/form/child-growth-development-outcomes
November 01, 2024 - Vision, Hearing, and Developmental Screening and Followup
Research Protocol
December 2, … Vision, Hearing, and Developmental Screening and Followup
Research Protocol
August 2, 2024 … Research Protocol
December 22, 2023
The Effect of Dietary Digestible Carbohydrate Intake on Risk … Research Protocol
December 21, 2023
The Effect of Dietary Digestible Carbohydrate Intake on Risk … Screening and Followup
SEAD Portal
Dec 02, 2024
SEAD Submission Form for Medical
-
effectivehealthcare-admin.ahrq.gov/products/antipsychotics-children/research-protocol
December 01, 2019 - perspective
Timing: See KQ1 above
Settings: See KQ1 above
Question 4: Do the effectiveness and risks … be rated as high risk of bias. … The overall risk of bias will be considered low only if all components are rated as having a low risk … The risk of bias for all other studies will be rated as unclear. … Data Synthesis
For each study, we will analyze comparisons between dichotomous outcomes using risk
-
effectivehealthcare-admin.ahrq.gov/products/allocation-scarce-resources/protocol
April 01, 2020 - Actions taken in advance to prepare for large-scale public health (e.g., stockpiling). … rather than performed in duplicate as for the original report. … Risk of bias (quality) assessment: We will use five critical appraisal criteria consistent with the … Vision, Hearing, and Developmental Screening and Followup
Research Protocol
May 02, 2024 … Effective Health Care Program, Agency for Healthcare Research and Quality, Rockville, MD.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/opioid-treatments-chronic-pain-protocol.pdf
December 19, 2018 - addressed the risks and benefits of opioids for chronic pain, dosing strategies, and risk
assessment … long-term opioid therapy only when benefits are
likely to exceed risks; use risk mitigation strategies … strategies, including (1) opioid management plans,
(2) patient education, (3) urine drug screening, … mitigation
strategies,
including (1)
opioid
management plans,
(2) patient
education, (3)
urine drug
screening … The effectiveness and risks of long-term opioid therapy for
chronic pain: a systematic review for a
-
effectivehealthcare-admin.ahrq.gov/products/mental-illness-heart/research-protocol
December 01, 2019 - shortened life expectancies relative to the general population to an extent that is not explained by suicide … Individuals who are taking antipsychotics and consequently at risk for elevated lipid levels … or
Individuals who are taking antipsychotics and consequently at risk for elevated lipid levels … Articles included by either reviewer will undergo full-text screening. … At the full-text screening stage, two independent reviewers must agree on a final inclusion/exclusion
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/depression-treatment-ssri_research-protocol.pdf
June 15, 2010 - Harms associated with any
of these interventions are evaluated in KQ2 and can include suicide, sexual … We have selected the Newcastle Ottawa Quality Assessment Tool13 to assess risk of bias
for observational … Studies that pass the
first screening for fatal flaws will be classified into high or low risk of bias … and Laird random-effects model to generate pooled measures
of treatment effect (i.e., estimates of relative … Screening for child and adolescent depression
in primary care settings: a systematic evidence review
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-3.xlsx
September 30, 2015 - body mass index; CI = confidence interval; COWS = Clinical Opiate Withdrawal Score; DAST = Drug Abuse Screening … care provider; RCT = randomized controlled trial; RMDQ = Roland Morris Disability Questionnaire; RR = relative … CI 2.05 to 2.96, p<0.001
Anxiety: 505/22097 vs. 6174/152194; aIRR 1.79, 95% CI 1.48 to 2.15, p<0.001
Suicide … D
Any opioid-related event: 5.3% vs. 6.1% vs. 3.4% vs. 3.6%, p<0.0001
Suicide (fatal or nonfatal): 1.0% … of suicide: aHR 3.63 (95% CI 1.42 to 9.25) vs. aHR 4.47 (95% CI 1.68 to 11.88) vs. aHR 1.29 (95% CI
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy_executive.pdf
January 27, 2012 - or who prefer disulfiram and understand the relative risks
of taking the drug; and (3) to have specialist … the risk of bias for
each study. … between acamprosate and naltrexone, whereas the risks
of headache and vomiting were higher for those … Behavioral counseling after
screening for alcohol misuse in primary care: a systematic review
and … Screening, Behavioral
Counseling, and Referral in Primary Care To Reduce Alcohol
Misuse.
-
effectivehealthcare-admin.ahrq.gov/products/form/measurement-criteria-qdr/draft-comments
December 01, 2024 - Vision, Hearing, and Developmental Screening and Followup
Research Protocol
August 2, 2024 … Multiple Cancer Screening: A Systematic Review
Research Protocol
June 26, 2024
Mindfulness-Based … Research Protocol
December 22, 2023
The Effect of Dietary Digestible Carbohydrate Intake on Risk … Research Protocol
December 21, 2023
The Effect of Dietary Digestible Carbohydrate Intake on Risk … Cardiovascular Disease
Research Protocol
December 8, 2023
Implementation of Recommended Screening
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1406.pdf
June 01, 2014 - In these cases,
patients are exposed to prolonged and increased risk of suicide and death. … mixed clinical trial results, as well as safety risks of using a
controlled substance … treating depressed patients at high risk of suicide are also registered.36,37
Manufacturer and regulatory … , as
well as the risk of anticholinergic effects noted for scopolamine’s approved indications. … for suicide.
-
effectivehealthcare-admin.ahrq.gov/products/mhs4-opioid-stewardship/protocol
September 01, 2023 - Studies of Effectiveness
Literature Searches for Studies of Effectiveness
Data Extraction
Risk … However, opioids also carry well known risks, including for overdose, misuse, and opioid use disorder … the risk of bias of randomized controlled trials (RCTs) or the ROBINS-I tool for assessing the Risk … The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. … ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/mhs4-opioid-stewardship-protocol.pdf
July 01, 2023 - However, opioids also carry well known risks,
including for overdose, misuse, and opioid use disorder … Risk of Bias (Quality) Assessment
For studies that address Review Question 5 about the effectiveness … of PSPs, the primary
reviewer will use the Cochrane Collaboration’s tool for assessing the risk of … The Cochrane Collaboration's tool for assessing risk of bias in
randomised trials. … ROBINS-I: a tool for assessing risk of bias in non-randomised
studies of interventions.
-
effectivehealthcare-admin.ahrq.gov/products/cad-women-treatment/research
December 01, 2019 - States, treatment studies to date have primarily enrolled men and may not reflect the benefits and risks … of effectiveness in women due to demographic factors (≥65 or ≥80 years of age) or clinical factors (risk … factors that may modify clinical effectiveness--so that firmer conclusions can be reached about the risk … Research Protocol
Dec 22, 2023
The Effect of Dietary Digestible Carbohydrate Intake on Risk … Cardiovascular Disease
Research Protocol
Dec 08, 2023
Implementation of Recommended Screening
-
effectivehealthcare-admin.ahrq.gov/products/gout/research
March 01, 2020 - Review methods
We used standard systematic review methods including duplicate screening and data extraction … High-strength evidence supports the finding that ULT does not reduce the risk of acute gout attacks within … However, moderate-strength evidence supports a role for ULT in reducing the risk of acute gout attacks … Low-strength evidence supports treating to a specific target serum urate level to reduce the risk of … supports the finding that prophylactic therapy with low-dose colchicine or low dose NSAIDs reduces the risk
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/mental-illness-outcomes_disposition-comments.pdf
January 15, 2015 - risk population at risk for medical problems. … However, the epidemiological
characteristics and risk factors for suicide are very different
from those … Clinicians
can sometimes identify modifiable risks for suicide, with the
presumption that intervention … can reduce suicide risk. … (One might argue that
more frequent screenings for cardiovascular or diabetic risk
may be needed but
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ptsd-5-protocol-update-2023.pdf
January 01, 2023 - of bias using the Cochrane risk-of-bias tool for randomized trials
(RoB 2),16 and calculating standardized … Assessment of Methodological Risk of Bias of Individual Studies:
The EPC will conduct a risk of bias … RoB 2: a revised tool for assessing risk of bias in
randomised trials. BMJ. 2019;366:l4898. … Results for suicide- or self-directed violence-related outcomes
2. … RoB 2, A REVISED TOOL FOR ASSESSING RISK OF BIAS IN RANDOMISED
TRIALS: ASSESSMENT ELEMENTS
1.1) Was
-
effectivehealthcare-admin.ahrq.gov/products/form/menopausal-symptoms
February 01, 2025 - Vision, Hearing, and Developmental Screening and Followup
Research Protocol
August 2, 2024 … Multiple Cancer Screening: A Systematic Review
Research Protocol
June 26, 2024
Mindfulness-Based … Research Protocol
December 22, 2023
The Effect of Dietary Digestible Carbohydrate Intake on Risk … Research Protocol
December 21, 2023
The Effect of Dietary Digestible Carbohydrate Intake on Risk … Cardiovascular Disease
Research Protocol
December 8, 2023
Implementation of Recommended Screening
-
effectivehealthcare-admin.ahrq.gov/products/antipsychotics-children-update/research-protocol
April 01, 2020 - Lastly, differences in some harms outcomes (e.g., weight gain and metabolic risks) have been shown to … ideations or behaviors, or death by suicide*
Long-term (≥ 6 month followup) school performance and … We will track the screening and selection results in EndNote.
C. … The risk of bias for all other studies will be rated as medium. … For binary outcomes, we will use a relative risk (RR) of 0.75 and 1.25 to represent clinically important
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/epilepsy-medicine_surveillance.pdf
August 01, 2012 - The risk of
being seizure free for either 6–12 or 24 months
was significantly lower for newer antiepileptic … ,
HLA-B 1502 genotyping
could be used as a screening
tool and use of tegretol
should be avoided. … Suicidal risk and suicide attempts in
people treated with antiepileptic drugs for
epilepsy. … , suicide
attempts
Antiepileptic drugs probably do not have an impact on
suicidality
Misra, 201219 … The risk of being seizure
free for either 6–12 or 24 months was significantly lower
for newer antiepileptic
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/epilepsy-medicine_surveillance.pdf
August 01, 2012 - The risk of
being seizure free for either 6–12 or 24 months
was significantly lower for newer antiepileptic … ,
HLA-B 1502 genotyping
could be used as a screening
tool and use of tegretol
should be avoided. … Suicidal risk and suicide attempts in
people treated with antiepileptic drugs for
epilepsy. … , suicide
attempts
Antiepileptic drugs probably do not have an impact on
suicidality
Misra, 201219 … The risk of being seizure
free for either 6–12 or 24 months was significantly lower
for newer antiepileptic